Northwell Cancer Institute

450 Lakeville Road
New Hyde Park, New York 11042

We've found

1 trials

at this facility

A Study to Evaluate the Efficacy and Safety of Pemigatinib (INCB054828) in Subjects With Urothelial Carcinoma - (FIGHT-201)

Status: Enrolling, Phase II
Updated: 12/31/1969

from

New Hyde Park, NY

Use our guide to learn which trials are right for you!